Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc. (TERN)

Delisted
15 May 2026
NASDAQ (NGS) NASDAQ (NGS)
$
52. 95
-0.02
-0.0321%
$
4.77B Market Cap
- P/E Ratio
- Div Yield
6.33M Volume
-1.33 Eps
$ 52.97
Previous Close
Day Range
52.95 52.97
Year Range
2.65 53.19
Want to track TERN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Terns Pharmaceuticals, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
EG
Ethan Gilbert Rialto Wealth Management LLC
162 $605 $605 - -
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
45,953 $1.63M $2.42M $788,575.88 48.26%
GLF
Groupe La Francaise Groupe La Francaise
118,449 $6.24M $6.24M - -
RFL
Rossby Financial LLC Rossby Financial LLC
124 $6,546 $6,546 - -
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
2,023 $22,057.13 $106,653 $84,595.87 383.53%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
5,130 $270,453 $270,453 - -
KGL
Kilter Group LLC Kilter Group LLC
116 $872 $872 - -
Charles Hillier
Charles Hillier Cibra Capital Ltd.
151,440 $7.98M $7.98M - -
Nicole Reese
Nicole Reese WPG Advisers LLC
66 $3,480 $3,480 - -
Jon Borer
Jon Borer Capitolis Liquid Global Markets LLC
1.98M $79.82M $104.16M $24.34M 30.5%